Zanidatamab for HER2-amplified, Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer (HERIZON-BTC-01): a Multicentre, Single-Arm, Phase 2b StudyJames J. Harding,Jia Fan,Do-Youn Oh,Hye Jin Choi,Jin Won Kim,Heung-Moon Chang,Lequn Bao,Hui-Chuan Sun,Teresa Macarulla, Feng Xie,Jean-Phillippe Metges,Jie'er Ying,John Bridgewater,Myung-Ah Lee,Mohamedtaki A. Tejani,Emerson Y. Chen,Dong Uk Kim,Harpreet Wasan,Michel Ducreux,Yuanyuan Bao,Lisa Boyken, Jiafang Ma, Phillip Garfin,Shubham PantLANCET ONCOLOGY（2023）引用 73|浏览74暂无评分关键词metastatic biliary tract cancer,herizon-btc,single-armAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
